Human Epigenome Project—Up and Running Jane Bradbury

Total Page:16

File Type:pdf, Size:1020Kb

Human Epigenome Project—Up and Running Jane Bradbury Feature Human Epigenome Project—Up and Running Jane Bradbury pigenomics is one of the are switched on and off to produce a many ‘omics’ that is being person. And knowing more about the The Human Genome Project Etalked about in the wake of human epigenome may provide clues the Human Genome Project. But to what goes wrong in cancer and other … ‘provided the blueprint, what is an epigenome, and why have diseases. the Wellcome Trust Sanger Institute for life but the epigenome What Is Epigenetics? (Hinxton, United Kingdom) and will tell us how this whole Epigenomics AG (Berlin, Germany) Most people have a fair idea of what recently announced the launch of the is meant by genetics. They know that thing gets executed’. Human Epigenome Project (HEP), characteristics such as eye colour are a fi ve-year undertaking during which specifi ed by the DNA sequence within DNA methylation sites throughout their genome. But not everything is That ‘something else’ is chemical the human genome will be mapped? that simple. For example, genetically modifi cations of genes that are The HEP is the brainchild of identical twins can be very different. heritable from one cell generation immunogeneticist Stephan Beck of the ‘One might be normal, while the to the next and that affect gene Sanger Institute and Alexander Olek, other is autistic’, explains chromatin expression but do not alter the DNA chief executive offi cer of Epigenomics researcher David Allis (Rockefeller sequence. Epigenetic modifi cations can AG. The Human Genome Project, University, New York, United States). affect the DNA itself or the proteins explains Olek, ‘provided the blueprint ‘We can’t explain that on the basis that package the DNA into chromatin. for life, but the epigenome will tell us of pure genetics because the DNA is Developmental geneticist Wolf Reik how this whole thing gets executed’, identical. Something else must be at (The Babraham Institute, Cambridge, what determines when and where genes play’. United Kingdom) describes these modifi cations as ‘red and green traffi c lights that are superimposed on top of the genome to tell the genes whether Box 1. The Same but Different they should be active or inactive’. For Geneticist Emma Whitelaw (University of Sydney, Australia) studies phenomena in mice similar individual cells, this code on top of a to those seen in human monozygotic twins, whereby genetically identical individuals can look code helps to determine whether a cell or behave very differently. About a decade ago, she explains, ‘we noticed that in a litter of mice is a blood cell, a fat cell, or something that had all stably inherited a transgene at a specifi c locus, some mice expressed the transgene, else. And in the case of monozygotic but others didn’t’. This variable gene expressivity in genetically identical animals suggested that twins, unexpected differences may some kind of epigenetic mark had occurred differentially between individuals by chance. Similarly, result from chance variations in this identical mice carrying the agouti viable yellow coat colour gene can range in colour from yellow superimposed code (Box 1). through mottled to brown, depending on whether the gene is expressed or not. And while a The study of these modifi cations— mutation in the axin gene called axin-fused produces mice with kinky tails, the degree of kinkiness what they are, how they are laid varies among genetically down, and the processes that they identical littermates (Figure 1). control—is the fi eld of research known For all these mice, Whitelaw as epigenetics. An epigenome is the has discovered that the description of these modifi cations mysterious epigenetic marks across the whole genome, but unlike responsible for variable the genome DNA sequence, each expressivity are inherited organism has multiple epigenomes— between sexual generations. for example, in different cell types— So, in the case of the agouti viable yellow mice, yellow mice Copyright: © 2003 Jane Bradbury. This is an open- have more yellow offspring access article distributed under the terms of the than mottled or brown Creative Commons Attribution License, which offspring. Variable expressivity permits unrestricted use, distribution, and reproduction in any medium, provided the original may be a quicker way to deal work is properly cited. with environmental change than DNA mutation and, Abbreviations: HEP, Human Epigenome Project; MHC, DOI: 10.1371/journal/pbio.0000082.g001 major histocompatibility complex suggests Whitelaw, it may Figure 1. Spot the Difference: Same Genes but a Different Kink be that variable expressivity Jane Bradbury is a freelance science news in the Tail writer based in Cambridge, United Kingdom. E-mail: is involved in some way in (Photograph courtesy of Emma Whitelaw, University of [email protected] evolution. Sydney, Australia.) DOI: 10.1371/journal/pbio.0000082 PLoS Biology | http://biology.plosjournals.org Volume 1 | Issue 3 | Page 316 that may change during its lifetime in enormous undertaking. ‘Knowing the DNA methylation sites throughout the response to environmental cues. methylation sequence’, says Bird, ‘will entire MHC region, the consortium be an essential backdrop to future set out to look at the 150 expressed DNA Methylation research on DNA methylation and its genes within this region, explains Beck. Methylated DNA was the fi rst biological effects’. Allis agrees that For each gene, the scientists chose epigenetic mark to be discovered. DNA methylation is an important part two areas to analyse for methylation, That this epigenetic modifi cation is of epigenetic marking, but ‘although each about 500 basepairs long. ‘One important is suggested by the waves mapping DNA methylation patterns is window was in what we thought was of demethylation and de novo (new) the logical and good place to start, by the promoter region’, says Beck, methylation that occur at specifi c its lonesome it won’t explain the whole ‘and the other corresponded to the stages during the development of an epigenetic phenomenon’. most CpG-rich region in the gene’. animal from a fertilised egg. Soon Beck and Olek began thinking about The promoter regions are the places after fertilisation, there is a massive mapping the human epigenome more where the elements that control gene active loss of methylation from the than fi ve years ago. Even as long ago expression are often located, and DNA paternal genome, explains Reik. At the as 1998, explains Olek, ‘it was pretty methylation occurs at cytosine residues same time, the maternal genome loses natural to be thinking about what within CpG motifs, hence the choice of some methyl groups through passive would come after the Human Genome CpG-rich regions. demethylation. ‘We think this process Project, and Stephan believed that The methylation status of more erases all the epigenetic memory in the it had to be methylation sequencing than 100, 000 sites was determined gametes [sperm and egg cells] except because that has the potential to tell during the three-year pilot study and for some special imprinted genes whose us about the hundreds of genomes we the results analysed to show where expression depends on whether they really have’. there were methylation differences are of maternal or parental origin’, says In October 2000, the Human in the MHC between different Reik. Later in development, widespread Epigenome Consortium (the Sanger tissues (Figure 2). ‘We found major de novo DNA methylation occurs in a Institute, Epigenomics AG, and the methylation differences between loci process known as reprogramming. De Centre National de Génotypage in and between tissues’, says Beck, ‘and novo methylation rarely occurs after Evry, France) started a European we are particularly interested in what an early developmental event known Union-funded pilot project to map we call methylation variable positions as gastrulation, except in cancer cells the methylation sites within the major (MVPs), which we believe will advance where special unmethylated regions histocompatibility complex (MHC) our ability to understand and diagnose of the genome, known as CpG islands, region in seven different human human disease’. Olek echoes Beck’s often become methylated. tissues. Rather than look at all the satisfaction with the results to date. ‘We ‘People generally agree that DNA methylation is important for imprinting and reprogramming’, says Reik, ‘but not everyone agrees that it plays a role in DNA activation and inactivation during development’, a role fi rst proposed more than 25 years ago. ‘People are still hesitant about saying that DNA methylation is important in making sure the right genes are expressed in the right cells at the right time because until recently we have had relatively few good examples’, says DNA methylation expert Adrian Bird (The Wellcome Trust Centre for Cell Biology, Edinburgh, United Kingdom). Many people have reported correlations between methylation states and gene activity but, says Reik, ‘you can look at such correlations until the cows come home and it tells you nothing about causality’. The HEP Pilot DOI: 10.1371/journal/pbio.0000082.g002 Even given the doubts about the Figure 2. Example of HEP Methylation Data for the BAT8 Gene, an MHC-Linked Histone exact role of DNA methylation, Bird, Methyltransferase Allis, and Reik believe that mapping In this case, two regions marked in red were analysed in 31 samples (rows) from seven tissues (blocks of rows). The predicted structure of the gene is shown below with methylation patterns across the coloured boxes indicating the exons. As part of the launch of the HEP on October 7, human genome, which is what the 2003, these data and others, together with experimental details of the pilot study, were HEP plans to do, is a worthwhile albeit released at www.epigenome.org. PLoS Biology | http://biology.plosjournals.org Volume 1 | Issue 3 | Page 317 can see that there is hidden treasure in way’.
Recommended publications
  • The 4D Nucleome Project
    The 4D nucleome project The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Dekker, Job et al. “The 4D Nucleome Project.” Nature 549, no. 7671 (September 2017): 219–226 © 2017 Macmillan Publishers Limited, part of Springer Nature As Published http://dx.doi.org/10.1038/NATURE23884 Publisher Nature Publishing Group Version Author's final manuscript Citable link http://hdl.handle.net/1721.1/114838 Terms of Use Creative Commons Attribution-Noncommercial-Share Alike Detailed Terms http://creativecommons.org/licenses/by-nc-sa/4.0/ HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Nature. Manuscript Author Author manuscript; Manuscript Author available in PMC 2017 September 27. Published in final edited form as: Nature. 2017 September 13; 549(7671): 219–226. doi:10.1038/nature23884. The 4D Nucleome Project Job Dekker1, Andrew S. Belmont2, Mitchell Guttman3, Victor O. Leshyk4, John T. Lis5, Stavros Lomvardas6, Leonid A. Mirny7, Clodagh C. O’Shea8, Peter J. Park9, Bing Ren10, Joan C. Ritland Politz11, Jay Shendure12, Sheng Zhong4, and the 4D Nucleome Network13 1Program in Systems Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Howard Hughes Medical Institute, Worcester, MA 01605 2Department of Cell and Developmental Biology, University of Illinois, Urbana-Champaign, IL 61801 3Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125 4Department
    [Show full text]
  • Epigenome Chaos: Stochastic and Deterministic DNA Methylation Events Drive Cancer Evolution
    cancers Review Epigenome Chaos: Stochastic and Deterministic DNA Methylation Events Drive Cancer Evolution Giusi Russo 1, Alfonso Tramontano 2, Ilaria Iodice 1, Lorenzo Chiariotti 1 and Antonio Pezone 1,* 1 Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli “Federico II”, 80131 Naples, Italy; [email protected] (G.R.); [email protected] (I.I.); [email protected] (L.C.) 2 Department of Precision Medicine, University of Campania “L. Vanvitelli”, 80138 Naples, Italy; [email protected] * Correspondence: [email protected] or [email protected]; Tel.: +39-081-746-3614 Simple Summary: Cancer is a group of diseases characterized by abnormal cell growth with a high potential to invade other tissues. Genetic abnormalities and epigenetic alterations found in tumors can be due to high levels of DNA damage and repair. These can be transmitted to daughter cells, which assuming other alterations as well, will generate heterogeneous and complex populations. Deciphering this complexity represents a central point for understanding the molecular mechanisms of cancer and its therapy. Here, we summarize the genomic and epigenomic events that occur in cancer and discuss novel approaches to analyze the epigenetic complexity of cancer cell populations. Abstract: Cancer evolution is associated with genomic instability and epigenetic alterations, which contribute to the inter and intra tumor heterogeneity, making genetic markers not accurate to monitor tumor evolution. Epigenetic changes, aberrant DNA methylation and modifications of chromatin proteins, determine the “epigenome chaos”, which means that the changes of epigenetic traits are Citation: Russo, G.; Tramontano, A.; randomly generated, but strongly selected by deterministic events.
    [Show full text]
  • The International Human Epigenome Consortium (IHEC): a Blueprint for Scientific Collaboration and Discovery
    The International Human Epigenome Consortium (IHEC): A Blueprint for Scientific Collaboration and Discovery Hendrik G. Stunnenberg1#, Martin Hirst2,3,# 1Department of Molecular Biology, Faculties of Science and Medicine, Radboud University, Nijmegen, The Netherlands 2Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada V6T 1Z4. 3Canada’s Michael Smith Genome Science Center, BC Cancer Agency, Vancouver, BC, Canada V5Z 4S6 #Corresponding authors [email protected] [email protected] Abstract The International Human Epigenome Consortium (IHEC) coordinates the generation of a catalogue of high-resolution reference epigenomes of major primary human cell types. The studies now presented (cell.com/XXXXXXX) highlight the coordinated achievements of IHEC teams to gather and interpret comprehensive epigenomic data sets to gain insights in the epigenetic control of cell states relevant for human health and disease. One of the great mysteries in developmental biology is how the same genome can be read by cellular machinery to generate the plethora of different cell types required for eukaryotic life. As appreciation grew for the central roles of transcriptional and epigenetic mechanisms in specification of cellular fates and functions, researchers around the world encouraged scientific funding agencies to develop an organized and standardized effort to exploit epigenomic assays to shed additional light on this process (Beck, Olek et al. 1999, Jones and Martienssen 2005, American Association for Cancer Research Human Epigenome Task and European Union 2008). In March 2009, leading scientists and international health research funding agency representatives were invited to a meeting in Bethesda (MD, USA) to gauge the level of interest in an international epigenomics project and to identify potential areas of focus.
    [Show full text]
  • Integrative Analysis for Elucidating Transcriptomics Landscapes of Glucocorticoid-Induced Osteoporosis
    fcell-08-00252 April 13, 2020 Time: 17:59 # 1 ORIGINAL RESEARCH published: 16 April 2020 doi: 10.3389/fcell.2020.00252 Integrative Analysis for Elucidating Transcriptomics Landscapes of Glucocorticoid-Induced Osteoporosis Xiaoxia Ying1†, Xiyun Jin2†, Pingping Wang2†, Yuzhu He1, Haomiao Zhang1, Xiang Ren1, Songling Chai1, Wenqi Fu1, Pengcheng Zhao1, Chen Chen1, Guowu Ma1* and Huiying Liu1* 1 2 Edited by: School of Stomatology, Dalian Medical University, Dalian, China, School of Life Sciences and Technology, Harbin Institute Yongchun Zuo, of Technology, Harbin, China Inner Mongolia University, China Reviewed by: Osteoporosis is the most common bone metabolic disease, characterized by bone Liang Yu, mass loss and bone microstructure changes due to unbalanced bone conversion, Xidian University, China Yanshuo Chu, which increases bone fragility and fracture risk. Glucocorticoids are clinically used to The University of Texas MD Anderson treat a variety of diseases, including inflammation, cancer and autoimmune diseases. Cancer Center, United States However, excess glucocorticoids can cause osteoporosis. Herein we performed an *Correspondence: Guowu Ma integrated analysis of two glucocorticoid-related microarray datasets. The WGCNA [email protected] analysis identified 3 and 4 glucocorticoid-related gene modules, respectively. Differential Huiying Liu expression analysis revealed 1047 and 844 differentially expressed genes in the two [email protected] datasets. After integrating differentially expressed glucocorticoid-related genes, we †These authors have contributed equally to this work found that most of the robust differentially expressed genes were up-regulated. Through protein-protein interaction analysis, we obtained 158 glucocorticoid-related candidate Specialty section: This article was submitted to genes. Enrichment analysis showed that these genes are significantly enriched in the Epigenomics and Epigenetics, osteoporosis related pathways.
    [Show full text]
  • Epigenome-Wide Association Study (EWAS) on Lipids: the Rotterdam Study Kim V
    Braun et al. Clinical Epigenetics (2017) 9:15 DOI 10.1186/s13148-016-0304-4 RESEARCH Open Access Epigenome-wide association study (EWAS) on lipids: the Rotterdam Study Kim V. E. Braun1, Klodian Dhana1, Paul S. de Vries1,2, Trudy Voortman1, Joyce B. J. van Meurs3,4, Andre G. Uitterlinden1,3,4, BIOS consortium, Albert Hofman1,5, Frank B. Hu5,6, Oscar H. Franco1 and Abbas Dehghan1* Abstract Background: DNA methylation is a key epigenetic mechanism that is suggested to be associated with blood lipid levels. We aimed to identify CpG sites at which DNA methylation levels are associated with blood levels of triglycerides, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and total cholesterol in 725 participants of the Rotterdam Study, a population-based cohort study. Subsequently, we sought replication in a non-overlapping set of 760 participants. Results: Genome-wide methylation levels were measured in whole blood using the Illumina Methylation 450 array. Associations between lipid levels and DNA methylation beta values were examined using linear mixed-effect models. All models were adjusted for sex, age, smoking, white blood cell proportions, array number, and position on array. A Bonferroni-corrected p value lower than 1.08 × 10−7 was considered statistically significant. Five CpG sites annotated to genes including DHCR24, CPT1A, ABCG1,andSREBF1 were identified and replicated. Four CpG sites were associated with triglycerides, including CpG sites annotated to CPT1A (cg00574958 and cg17058475), ABCG1 (cg06500161), and SREBF1 (cg11024682). Two CpG sites were associated with HDL-C, including ABCG1 (cg06500161) and DHCR24 (cg17901584). No significant associations were observed with LDL-C or total cholesterol.
    [Show full text]
  • EPIGENOMICS: BEYOND Cpg ISLANDS
    REVIEWS EPIGENOMICS: BEYOND CpG ISLANDS Melissa J. Fazzari* and John M. Greally† Epigenomic studies aim to define the location and nature of the genomic sequences that are epigenetically modified. Much progress has been made towards whole-genome epigenetic profiling using molecular techniques, but the analysis of such large and complex data sets is far from trivial given the correlated nature of sequence and functional characteristics within the genome. We describe the statistical solutions that help to overcome the problems with data-set complexity, in anticipation of the imminent wealth of data that will be generated by new genome- wide epigenetic profiling and DNA sequence analysis techniques. So far, epigenomic studies have succeeded in identifying CpG islands, but recent evidence points towards a role for transposable elements in epigenetic regulation, causing the fields of study of epigenetics and transposable element biology to converge. Epigenetic inheritance involves the transmission of issues of correlation and causality — for example, the information not encoded in DNA sequences from cell DNA sequence feature might be the effect of the epige- to daughter cell or from generation to generation. netic process rather than mechanistically involved in Covalent modifications of the DNA or its packaging directing it. As new techniques to characterize epigenetic histones are responsible for transmitting epigenetic processes throughout the genome are being applied, we information. Epigenomics can be defined as a genome- have the potential to generate large amounts of data to wide approach to studying epigenetics. This term facilitate epigenomic studies. It is a good time now to encompasses whole-genome studies of epigenetic consider these issues so that we can design our analytical processes and the identification of the DNA sequences approaches appropriately.
    [Show full text]
  • A Machine Learning Framework for Precise 3D Domain Boundary Prediction at Base-Level Resolution
    bioRxiv preprint doi: https://doi.org/10.1101/2020.09.03.282186; this version posted September 29, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. preciseTAD: A machine learning framework for precise 3D domain boundary prediction at base-level resolution Spiro C. Stilianoudakis1 ([email protected]), Mikhail G. Dozmorov1* (mikhail.dozmorov@ vcuhealth.org) 1 Dept. of Biostatistics, Virginia Commonwealth University, Richmond, VA, 23298, USA * To whom correspondence should be addressed Abstract The low resolution of high-throughput chromatin conformation capture data limits the precise mapping of boundaries of topologically associating domains and chromatin loops. We developed preciseTAD, an optimized random forest model trained on high-resolution genome annotation data (e.g., CTCF ChIP- seq) to predict the location of domain boundaries at base-level resolution. Distance between boundaries and annotations, random under-sampling, and transcription factor binding sites resulted in best model performance. preciseTAD boundaries were more enriched for CTCF, RAD21, SMC3, and ZNF143, and conserved across cell lines. Using genome annotations, pre-trained models can detect boundaries in cells without Hi-C data. preciseTAD is available at https://bioconductor.org/packages/preciseTAD Keywords Hi-C, TAD, machine learning, random forest, DBSCAN Background The advent of chromosome conformation capture (3C) sequencing technologies, and its successor Hi-C, have revealed a hierarchy of the 3-dimensional (3D) structure of the human genome such as chromatin loops [1], Topologically Associating Domains (TADs) [2,3], and A/B compartments [4].
    [Show full text]
  • Epigenetics and Systems Biology 1St Edition Ebook
    EPIGENETICS AND SYSTEMS BIOLOGY 1ST EDITION PDF, EPUB, EBOOK Leonie Ringrose | 9780128030769 | | | | | Epigenetics and Systems Biology 1st edition PDF Book Regulation of lipogenic gene expression by lysine-specific histone demethylase-1 LSD1. BEDTools: a flexible suite of utilities for comparing genomic features. New technologies are also needed to study higher order chromatin organization and function. For example, acetylation of the K14 and K9 lysines of the tail of histone H3 by histone acetyltransferase enzymes HATs is generally related to transcriptional competence. The idea that multiple dynamic modifications regulate gene transcription in a systematic and reproducible way is called the histone code , although the idea that histone state can be read linearly as a digital information carrier has been largely debunked. Namespaces Article Talk. It seems existing structures act as templates for new structures. As part of its efforts, the society launched a journal, Epigenetics , in January with the goal of covering a full spectrum of epigenetic considerations—medical, nutritional, psychological, behavioral—in any organism. Sooner or later, with the advancements in biomedical tools, the detection of such biomarkers as prognostic and diagnostic tools in patients could possibly emerge out as alternative approaches. Genotype—phenotype distinction Reaction norm Gene—environment interaction Gene—environment correlation Operon Heritability Quantitative genetics Heterochrony Neoteny Heterotopy. The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover. Khan, A. Hidden categories: Webarchive template wayback links All articles lacking reliable references Articles lacking reliable references from September Wikipedia articles needing clarification from January All articles with unsourced statements Articles with unsourced statements from June This mechanism enables differentiated cells in a multicellular organism to express only the genes that are necessary for their own activity.
    [Show full text]
  • Pharmacogene Regulatory Elements: from Discovery to Applications
    Smith et al. Genome Medicine 2012, 4:45 http://genomemedicine.com/content/4/5/45 REVIEW Pharmacogene regulatory elements: from discovery to applications Robin P Smith1,2†, Ernest T Lam2,3†, Svetlana Markova1, Sook Wah Yee1* and Nadav Ahituv1,2* Pharmacogenomics and gene regulatory elements: Abstract an emerging picture Regulatory elements play an important role in the Most pharmacogenomics studies to date have focused on variability of individual responses to drug treatment. coding variants of pharmacologically important proteins. This has been established through studies on three However, well-supported examples of variants in regu la- classes of elements that regulate RNA and protein tory elements of genes involved in drug response, such as abundance: promoters, enhancers and microRNAs. drug metabolizing enzymes and transporters (see review Each of these elements, and genetic variants within by Georgitsi et al. [1]), show that variants in noncoding them, are being characterized at an exponential pace regulatory sequences are also likely to be important by next-generation sequencing (NGS) technologies. In (Table 1). Th ree classes of regulatory elements have been this review, we outline examples of how each class of studied in this context: promoters, enhancers and element aff ects drug response via regulation of drug microRNAs (miRNAs). Each of these has a direct impact targets, transporters and enzymes. We also discuss on the abundance of messenger RNA (mRNA) (in the case the impact of NGS technologies such as chromatin of promoters and enhancers) and protein (in the case of immunoprecipitation sequencing (ChIP-Seq) and RNA miRNAs). Genetic variation within each of these elements sequencing (RNA-Seq), and the ramifi cations of new has been linked to human disease as well as interindividual techniques such as high-throughput chromosome diff erences in drug response.
    [Show full text]
  • Long Non-Coding Rnas, the Dark Matter: an Emerging Regulatory Component in Plants
    International Journal of Molecular Sciences Review Long Non-Coding RNAs, the Dark Matter: An Emerging Regulatory Component in Plants Muhammad Waseem 1,2,3 , Yuanlong Liu 1,2,3 and Rui Xia 1,2,3,* 1 State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources, South China Agricultural University, Guangzhou 510640, China; [email protected] (M.W.); [email protected] (Y.L.) 2 Guangdong Laboratory for Lingnan Modern Agriculture, South China Agricultural University, Guangzhou 510640, China 3 Key Laboratory of Biology and Germplasm Enhancement of Horticultural Crops in South China, Ministry of Agriculture and Rural Affairs, South China Agricultural University, Guangzhou 510640, China * Correspondence: [email protected] Abstract: Long non-coding RNAs (lncRNAs) are pervasive transcripts of longer than 200 nucleotides and indiscernible coding potential. lncRNAs are implicated as key regulatory molecules in various fundamental biological processes at transcriptional, post-transcriptional, and epigenetic levels. Ad- vances in computational and experimental approaches have identified numerous lncRNAs in plants. lncRNAs have been found to act as prime mediators in plant growth, development, and tolerance to stresses. This review summarizes the current research status of lncRNAs in planta, their classification based on genomic context, their mechanism of action, and specific bioinformatics tools and resources for their identification and characterization. Our overarching goal is to summarize recent progress on understanding the regulatory role of lncRNAs in plant developmental processes such as flowering time, reproductive growth, and abiotic stresses. We also review the role of lncRNA in nutrient stress and the ability to improve biotic stress tolerance in plants.
    [Show full text]
  • 13.2 News Feat Epigenetic
    news feature Altered states Changes to the genome that don’t affect DNA sequence may help to explain differences between genetically identical twins. Might these ‘epigenetic’ phenomena also underlie common diseases? Carina Dennis investigates. arie and Jo — not their real names — are twins, genetically identical Mand raised in a happy home. Grow- ing up, both enjoyed sport and art, were equally good at school, and appeared simi- H. KING/CORBIS lar in almost every respect. But as adults, their lives and personalities diverged: in her early twenties, following episodes of hallucinations and delusions, Marie was diagnosed with schizophrenia. Such examples have long baffled geneti- cists. Despite sharing the same DNA and often the same environment, ‘identical’ twins can sometimes show striking differ- ences. Now some researchers are beginning to investigate whether subtle modifications to the genome that don’t alter its DNA sequence, known as epigenetic changes, may provide the answer. In doing so, they hope to shed light on the mysterious roots of com- mon diseases — such as schizophrenia and diabetes — that burden society as a whole. The idea that epigenetics underpins many of the world’s health scourges is still highly speculative. “Most geneticists believe that the essence of all human disease is related Spot the difference: colour-coded epigenetic microarrays could show why ‘identical’ twins aren’t the same. to DNA-sequence variation,” says Arturas Petronis, a psychiatrist at the University of important epigenetic mechanism. Inside the stumbled into the subject from conventional Toronto in Canada. But with the genomics nucleus, strands of DNA wrap around pro- genetics, discovering that the mutated gene revolution having yet to yield the hoped-for teins called histones, and then coil up for a rare condition exerts its effect by avalanche of genes that confer susceptibility again into a densely packed structure called influencing epigenetic modifications else- to common diseases, Petronis is not alone in chromatin.
    [Show full text]
  • Integrative Functional Genomics Identifies an Enhancer Looping to the SOX9 Gene Disrupted by the 17Q24.3 Prostate Cancer Risk Locus
    Downloaded from genome.cshlp.org on October 1, 2021 - Published by Cold Spring Harbor Laboratory Press Research Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus Xiaoyang Zhang,1,4 Richard Cowper-SalÁlari,1,2,4 Swneke D. Bailey,3 Jason H. Moore,1,2 and Mathieu Lupien1,3,5 1Department of Genetics and Institute for Quantitative Biomedical Sciences, Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, New Hampshire 03756, USA; 2Computational Genetics Laboratory and Department of Genetics, Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, New Hampshire 03756, USA; 3Ontario Cancer Institute, Princess Margaret Hospital– University Health Network, and the Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada Genome-wide association studies (GWAS) are identifying genetic predisposition to various diseases. The 17q24.3 locus harbors the single nucleotide polymorphism (SNP) rs1859962 that is statistically associated with prostate cancer (PCa). It defines a 130-kb linkage disequilibrium (LD) block that lies in an ~2-Mb gene desert area. The functional biology driving the risk associated with this LD block is unknown. Here, we integrate genome-wide chromatin landscape data sets, namely, epigenomes and chromatin openness from diverse cell types. This identifies a PCa-specific enhancer within the rs1859962 risk LD block that establishes a 1-Mb chromatin loop with the SOX9 gene. The rs8072254 and rs1859961 SNPs mapping to this enhancer impose allele-specific gene expression. The variant allele of rs8072254 facilitates androgen receptor (AR) binding driving increased enhancer activity. The variant allele of rs1859961 decreases FOXA1 binding while increasing AP-1 binding.
    [Show full text]